TickerFactsScreenerDevelopers

TransMedics Group, Inc. (TMDX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $20.24M2019: $20.09M2020: $24.58M2021: $25.58M2022: $201.18M2023: $394.81M$394.81M
2018Cash & Equivalents (USD)2023
Fiscal YearCash & EquivalentsChange YoY
2023$394.81M+96.2%
2022$201.18M+686.5%
2021$25.58M+4.1%
2020$24.58M+22.3%
2019$20.09M-0.7%
2018$20.24M—